Rapid automated determination of lipid hydroperoxide concentrations and total antioxidant status of serum samples from patients infected with HIV: Elevated lipid hydroperoxide concentrations and depleted total antioxidant capacity of serum samples

American Journal of Clinical Pathology

Volumn 109, Issue 3, 1998, Pages 268-273

  McLemore, Jerri L ^a   Beeley, Peggy ^a   Thorton, Karla ^a   Morrisroe, Kevin ^b   Blackwell, Walter ^a   Dasgupta, Amitava ^c,d  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b VA Medical Center   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

AIDS; Antioxidant capacity; Lipid hydroperoxide

Indexed keywords

FREE RADICAL; LIPID HYDROPEROXIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIOXIDANT ACTIVITY; ARTICLE; AUTOMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID PEROXIDATION; MALNUTRITION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031909887     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.3.268     Document Type: Article

References (22)

1. Specter S, Bendinelli M, Friedman H. Viruses and immunosuppressions. In: Spector S, Bendinelli M, Friedman H eds. Virus Induced Immunosuppression. New York, NY: Plenum Press; 1989:pp 1-17.
2. Wong MC, Suite NDA, Labar DR. Seizures in human immunodeficiency virus infection. Arch Neurol. 1990;47:640-642.
3. Fantini J, Yahi N, Chermann JC. Human immunodeficiency virus can infect the apical and basolateral surfaces of human colonic epithelium. Proc Natl Acad Sci U S A. 1991; 88:9297-9301.
4. Macallan D, Noble C, Baldwin C, et al. Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr. 1993;58:417-424.
5. Southern PA, Powis G. Oxygen free radicals linked to many diseases. Mayo Clin Proc. 1988;63:381-389.
6. Passi S, DeLuca C, Picardo M, et al. I valori ematici deficitari degli acidi grassi polinnsaturi dei fosfolipidi, della vitamina E e della glutatione peossidasi come possibili fattori di rischio nell insorgenza e nello sviluppo della sindrome da immunodeficienza acquisita. G Ital Dermatol Venereol. 1990;125:125-130.
7. Beach R, Mantero-Antienza E, Shor-Posner G. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS. 1992;6:701-708.
8. Favier A, Sappey C, Leclerc P, et al. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Int. 1994;91:165-180.
9. Sonnerborg AC, Carlin G, Akerlund B, et al. Increased production of malonaldehyde in patients with HIV infection. Scand J Infect Dis. 1988;20:287-290.
10. Legrand-Poels S, Vaira D, Pincemail J, et al. Activation of human immunodeficiency virus type I by oxidative stress. AIDS Res Hum Retroviruses. 1990;6:1389-1397.
11. Roederer M, Staal FJ, Raju S, et al. Cytokine-stimulated human immunodeficiency virus replication inhibited by N acetyl cysteine. Proc Natl Acad Sci U S A. 1990;87:4884.
12. Malorni W, Rivabene R, Santini MT, et al. N-acetyl cysteine inhibits apoptosis and decreases viral particles in HIV chronically infected U937 cells. FEBS Lett. 1993;1327:75-78.
13. Pervaiz S, Harriman A, Gulliya KS. Protein damage by photo products of merocyanine 540. Free Radic Biol Med. 1992;12:389-396.
14. Gonzalez S, Pathak MA. Inhibition of ultraviolet induced formation of reactive oxygen species, lipid peroxidation erythema and skin photosensitization by polypodium leucotomas species. Photodermatol Photoimmunol Photomed. 1996;12:45-56.
15. Sharpe PC, McGrath LT, McClean E, et al. Effect of red wine consumption on lipoprotein (a) and other risk factors for atherosclerosis. QJM. 1995;88:101-108.
16. Wong GHW, McHugh T, Weber R, et al. Tumor necrosis factor selectively sensitizes human immunodeficiency virus infected cells to heat and radiation. Proc Natl Acad Sci U S A. 1991;88:4372-4376.
17. Staal FJ, Ela SW, Roederer M, et al. Glutathione deficiency and human immunodeficiency virus infection. Lancet. 1992;339:909-912.
18. Delmas-Beauvieux M, Peuchant E, Couchouron A, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene. Am J Clin Nutr. 1996;64:101-107.
19. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991;88:1785-1792.
20. Lunec JU, Halloran SP, White AC, et al. Free radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol. 1981;8:233-245.
21. Jialal I, Devraj S. Low density lipoprotein oxidation, antioxidants, and atherosclerosis: a clinical biochemistry perspective. Clin Chem. 1996;42:498-506.
22. Jialal I. A practical approach to the laboratory diagnosis of dyslipidemia. Am J Clin Pathol. 1996;106:128-138.